Human dendritic cell line models for DC differentiation and clinical DC vaccination studies

Journal of Leukocyte Biology

Volumn 84, Issue 6, 2008, Pages 1364-1373

  Santegoets, Saskia J A M ^a   Van Den Eertwegh, Alfons J M ^a   Van De Loosdrecht, Arjan A ^a   Scheper, Rik J ^a   De Gruijl, Tanja D ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Biology; Immunotherapy; Interstitial; Langerhans cell; MUTZ 3

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; CD34 SELECTION; CELL DIFFERENTIATION; CELL LINE; CELL STRAIN HL 60; DENDRITIC CELL; HUMAN; IN VITRO STUDY; LEUKEMIA CELL; PHENOTYPE; PRIORITY JOURNAL; REVIEW; VACCINATION;

CANCER VACCINES; CELL DIFFERENTIATION; CELL LINE; DENDRITIC CELLS; HUMANS; LEUKEMIA; MODELS, BIOLOGICAL;

EID: 57149111529     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0208092     Document Type: Review

References (103)

1. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B., Palucka, K. (2000) Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811.
2. Figdor, C. G., de Vries, I. J., Lesterhuis, W. J., Melief, C. J. (2004) Dendritic cell immunotherapy: mapping the way. Nat. Med. 10, 475-480.
3. Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S., Liu, Y. J. (1999) The nature of the principal type 1 interferon-producing cells in human blood. Science 284, 1835-1837.
4. Shortman, K., Liu, Y. J. (2002) Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2, 151-161.
5. Romani, N., Gruner, S., Brang, D., Kampgen, E., Lenz, A., Trockenbacher, B., Konwalinka, G., Fritsch, P. O., Steinman, R. M., Schuler, G. (1994) Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180, 83-93.
6. Caux, C., Vanbervliet, B., Massacrier, C., Dezutter-Dambuyant, C., Saint-Vis, B., Jacquet, C., Yoneda, K., Imamura, S., Schmitt, D., Banchereau, J. (1996) CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF α. J. Exp. Med. 184, 695-706.
7. Sallusto, F., Lanzavecchia, A. (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179, 1109-1118.
8. Romani, N., Reider, D., Heuer, M., Ebner, S., Kampgen, E., Eibl, B., Niederwieser, D., Schuler, G. (1996) Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J. Immunol. Methods 196, 137-151.
9. Strobl, H., Riedl, E., Scheinecker, C., Bello-Fernandez, C., Pickl, W. F., Rappersberger, K., Majdic, O., Knapp, W. (1996) TGF-β 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors. J. Immunol. 157, 1499-1507.
10. Zhou, L. J., Tedder, T. F. (1996) CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc. Natl. Acad. Sci. USA 93, 2588-2592.
11. Luft, T., Pang, K. C., Thomas, E., Hertzog, P., Hart, D. N., Trapani, J., Cebon, J. (1998) Type I IFNs enhance the terminal differentiation of dendritic cells. J. Immunol. 161, 1947-1953.
12. Mohamadzadeh, M., Berard, F., Essert, G., Chalouni, C., Pulendran, B., Davoust, J., Bridges, G., Palucka, A. K., Banchereau, J. (2001) Interleukin 15 skews monocyte differentiation into dendritic cells with features of Langerhans cells. J. Exp. Med. 194, 1013-1020.
13. Choudhury, B. A., Liang, J. C., Thomas, E. K., Flores-Romo, L., Xie, Q. S., Agusala, K., Sutaria, S., Sinha, I., Champlin, R. E., Claxton, D. F. (1999) Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, antileukemic T-cell responses. Blood 93, 780-786.
14. Charbonnier, A., Gaugler, B., Sainty, D., Lafage-Pochitaloff, M., Olive, D. (1999) Human acute myeloblastic leukemia cells differentiate in vitro into mature dendritic cells and induce the differentiation of cytotoxic T cells against autologous leukemias. Eur. J. Immunol. 29, 2567-2578.
15. Westers, T. M., Stam, A. G., Scheper, R. J., Regelink, J. C., Nieuwint, A. W., Schuurhuis, G. J., van de Loosdrecht, A. A., Ossenkoppele, G. J. (2003) Rapid generation of antigen-presenting cells from leukemic blasts in acute myeloid leukemia. Cancer Immunol. Immunother. 52, 17-27.
16. Houtenbos, I., Westers, T. M., Stam, A. G., de Gruijl, T. D., Scheper, R. J., Ossenkoppele, G. J., van de Loosdrecht, A. A. (2003) Serum-free generation of antigen presenting cells from acute myeloid leukemic blasts for active specific immunization. Cancer Immunol. Immunother. 52, 455-462.
17. Van Helden, S. F., van Leeuwen, F. N., Figdor, C. G. (2008) Human and murine model cell lines for dendritic cell biology evaluated. Immunol. Lett. 117, 191-197.
18. Santiago-Schwarz, F., Coppock, D. L., Hindenburg, A. A., Kern, J. (1994) Identification of a malignant counterpart of the monocyte-dendritic cell progenitor in an acute myeloid leukemia. Blood 84, 3054-3062.
19. Larsson, K., Lindstedt, M., Borrebaeck, C. A. (2006) Functional and transcriptional profiling of MUTZ-3, a myeloid cell line acting as a model for dendritic cells. Immunology 117, 156-166.
20. Masterson, A. J., Sombroek, C. C., De Gruijl, T. D., Graus, Y. M., van der Vliet, H. J., Lougheed, S. M., van den Eertwegh, A. J., Pinedo, H. M., Scheper, R. J. (2002) MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+ precursors. Blood 100, 701-703.
21. Czerniecki, B. J., Carter, C., Rivoltini, L., Koski, G. K., Kim, H. I., Weng, D. E., Roros, J. G., Hijazi, Y. M., Xu, S., Rosenberg, S. A., Cohen, P. A. (1997) Calcium ionophore-treated peripheral blood monocytes and dendritic cells rapidly display characteristics of activated dendritic cells. J. Immunol. 159, 3823-3837.
22. Koski, G. K., Schwartz, G. N., Weng, D. E., Czerniecki, B. J., Carter, C., Gress, R. E., Cohen, P. A. (1999) Calcium mobilization in human myeloid cells results in acquisition of individual dendritic cell-like characteristics through discrete signaling pathways. J. Immunol. 163, 82-92.
23. St Louis, D. C., Woodcock, J. B., Franzoso, G., Blair, P. J., Carlson, L. M., Murillo, M., Wells, M. R., Williams, A. J., Smoot, D. S., Kaushal, S., Grimes, J. L., Harlan, D. M., Chute, J. P., June, C. H., Siebenlist, U., Lee, K. P. (1999) Evidence for distinct intracellular signaling pathways in CD34+ progenitor to dendritic cell differentiation from a human cell line model. J. Immunol. 162, 3237-3248.
24. Davis, T. A., Saini, A. A., Blair, P. J., Levine, B. L., Craighead, N., Harlan, D. M., June, C. H., Lee, K. P. (1998) Phorbol esters induce differentiation of human CD34+ hemopoietic progenitors to dendritic cells: evidence for protein kinase C-mediated signaling. J. Immunol. 160, 3689-3697.
25. Tsuchiya, S., Yamabe, M., Yamaguchi, Y., Kobayashi, Y., Konno, T., Tada, K. (1980) Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer 26, 171-176.
26. Berges, C., Naujokat, C., Tinapp, S., Wieczorek, H., Hoh, A., Sadeghi, M., Opelz, G., Daniel, V. (2005) A cell line model for the differentiation of human dendritic cells. Biochem. Biophys. Res. Commun. 333, 896-907.
27. Tsuchiya, S., Kobayashi, Y., Goto, Y., Okumura, H., Nakae, S., Konno, T., Tada, K. (1982) Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res. 42, 1530-1536.
28. Hara, H., Tanishita, H., Yokoyama, S., Tajima, S., Yamamoto, A. (1987) Induction of acetylated low density lipoprotein receptor and suppression of low density lipoprotein receptor on the cells of human monocytic leukemia cell line (THP-1 cell). Biochem. Biophys. Res. Commun. 146, 802-808.
29. Tajima, S., Hayashi, R., Tsuchiya, S., Miyake, Y., Yamamoto, A. (1985) Cells of a human monocytic leukemia cell line (THP-1) synthesize and secrete apolipoprotein E and lipoprotein lipase. Biochem. Biophys. Res. Commun. 126, 526-531.
30. Koeffler, H. P., Golde, D. W. (1978) Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity. Science 200, 1153-1154.
31. Koeffler, H. P., Bar-Eli, M., Territo, M. C. (1981) Phorbol ester effect on differentiation of human myeloid leukemia cell lines blocked at different stages of maturation. Cancer Res. 41, 919-926.
32. Kiss, Z., Deli, E., Shoji, M., Koeffler, H. P., Pettit, G. R., Vogler, W. R., Kuo, J. F. (1987) Differential effects of various protein kinase C activators on protein phosphorylation in human acute myeloblastic leukemia cell line KG-1 and its phorbol ester-resistant subline KG-1a. Cancer Res. 47, 1302-1307.
33. Hulette, B. C., Rowden, G., Ryan, C. A., Lawson, C. M., Dawes, S. M., Ridder, G. M., Gerberick, G. F. (2001) Cytokine induction of a human acute myelogenous leukemia cell line (KG-1) to a CD1a+ dendritic cell phenotype. Arch. Dermatol. Res. 293, 147-158.
34. Hajas, G., Zsiros, E., Laszlo, T., Hajdu, P., Somodi, S., Rethi, B., Gogolak, P., Ludanyi, K., Panyi, G., Rajnavolgyi, E. (2004) New phenotypic, functional and electrophysiological characteristics of KG-1 cells. Immunol. Lett. 92, 97-106.
35. Collins, S. J., Ruscetti, F. W., Gallagher, R. E., Gallo, R. C. (1979) Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide. J. Exp. Med. 149, 969-974.
36. Breitman, T. R., Selonick, S. E., Collins, S. J. (1980) Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. USA 77, 2936-2940.
37. Miyaura, C., Abe, E., Kuribayashi, T., Tanaka, H., Konno, K., Nishii, Y., Suda, T. (1981) 1 α,25-Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells. Biochem. Biophys. Res. Commun. 102, 937-943.
38. Ball, E. D., Guyre, P. M., Shen, L., Glynn, J. M., Maliszewski, C. R., Baker, P. E., Fanger, M. W. (1984) γ Interferon induces monocytoid differentiation in the HL-60 cell line. J. Clin. Invest. 73, 1072-1077.
39. Rovera, G., Santoli, D., Damsky, C. (1979) Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester. Proc. Natl. Acad. Sci. USA 76, 2779-2783.
40. Fischkoff, S. A., Pollak, A., Gleich, G. J., Testa, J. R., Misawa, S., Reber, T. J. (1984) Eosinophilic differentiation of the human promyelocytic leukemia cell line, HL-60. J. Exp. Med. 160, 179-196.
41. Koski, G. K., Schwartz, G. N., Weng, D. E., Gress, R. E., Engels, F. H., Tsokos, M., Czerniecki, B. J., Cohen, P. A. (1999) Calcium ionophoretreated myeloid cells acquire many dendritic cell characteristics independent of prior differentiation state, transformation status, or sensitivity to biologic agents. Blood 94, 1359-1371.
42. Ziegler-Heitbrock, H. W., Thiel, E., Futterer, A., Herzog, V., Wirtz, A., Riethmuller, G. (1988) Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes. Int. J. Cancer 41, 456-461.
43. Cross, A. K., Richardson, V., Ali, S. A., Palmer, I., Taub, D. D., Rees, R. C. (1997) Migration responses of human monocytic cell lines to α- and β-chemokines. Cytokine 9, 521-528.
44. Neustock, P., Brand, J. M., Kruse, A., Kirchner, H. (1993) Cytokine production of the human monocytic cell line Mono Mac 6 in comparison to mature monocytes in peripheral blood mononuclear cells. Immunobiology 188, 293-302.
45. Ziegler-Heitbrock, H. W., Strobel, M., Kieper, D., Fingerle, G., Schlunck, T., Petersmann, I., Ellwart, J., Blumenstein, M., Haas, J. G. (1992) Differential expression of cytokines in human blood monocyte subpopulations. Blood 79, 503-511.
46. Ziegler-Heitbrock, H. W., Blumenstein, M., Kafferlein, E., Kieper, D., Petersmann, I., Endres, S., Flegel, W. A., Northoff, H., Riethmuller, G., Haas, J. G. (1992) In vitro desensitization to lipopolysaccharide suppresses tumor necrosis factor, interleukin-1 and interleukin-6 gene expression in a similar fashion. Immunology 75, 264-268.
47. Sundstrom, C., Nilsson, K. (1976) Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer 17, 565-577.
48. Nilsson, M., Nilsson, K., Forsbeck, K. (1989) Increased endocytosis and formation of multivesicular bodies in phorbol ester-stimulated human monoblastic U-937 cells. Exp. Cell Res. 181, 551-565.
49. Minta, J. O., Pambrun, L. (1985) In vitro induction of cytologic and functional differentiation of the immature human monocytelike cell line U-937 with phorbol myristate acetate. Am. J. Pathol. 119, 111-126.
50. Tetteroo, P. A., Massaro, F., Mulder, A., Schreuder-van Gelder, R., von dem Borne, A. E. (1984) Megakaryoblastic differentiation of proerythroblastic K562 cell-line cells. Leuk. Res. 8, 197-206.
51. Lozzio, B. B., Lozzio, C. B. (1977) Properties of the K562 cell line derived from a patient with chronic myeloid leukemia. Int. J. Cancer 19, 136.
52. Sutherland, J. A., Turner, A. R., Mannoni, P., McGann, L. E., Turc, J. M. (1986) Differentiation of K562 leukemia cells along erythroid, macrophage, and megakaryocyte lineages. J. Biol. Response Mod. 5, 250-262.
53. Lindner, I., Kharfan-Dabaja, M. A., Ayala, E., Kolonias, D., Carlson, L. M., Beazer-Barclay, Y., Scherf, U., Hnatyszyn, J. H., Lee, K. P. (2003) Induced dendritic cell differentiation of chronic myeloid leukemia blasts is associated with down-regulation of BCR-ABL. J. Immunol. 171, 1780-1791.
54. Hu, Z. B., Ma, W., Zaborski, M., MacLeod, R., Quentmeier, H., Drexler, H. G. (1996) Establishment and characterization of two novel cytokine-responsive acute myeloid and monocytic leukemia cell lines, MUTZ-2 and MUTZ-3. Leukemia 10, 1025-1040.
55. Quentmeier, H., Duschl, A., Hu, Z. B., Schnarr, B., Zaborski, M., Drexler, H. G. (1996) MUTZ-3, a monocytic model cell line for interleukin-4 and lipopolysaccharide studies. Immunology 89, 606-612.
56. Santegoets, S. J., Masterson, A. J., van der Sluis, P. C., Lougheed, S. M., Fluitsma, D. M., van den Eertwegh, A. J., Pinedo, H. M., Scheper, R. J., de Gruijl, T. D. (2006) A CD34+ human cell line model of myeloid dendritic cell differentiation: evidence for a CD14+CD11b+ Langerhans cell precursor. J. Leukoc. Biol. 80, 1337-1344.
57. Santegoets, S. J., Bontkes, H. J., Stam, A. G., Bhoelan, F., Ruizendaal, J. J., van den Eertwegh, A. J., Hooijberg, E., Scheper, R. J., de Gruijl, T. D. (2008) Inducing antitumor T cell immunity: comparative functional analysis of interstitial versus Langerhans dendritic cells in a human cell line model. J. Immunol. 180, 4540-4549.
58. Larregina, A. T., Falo Jr., L. D. (2005) Changing paradigms in cutaneous immunology: adapting with dendritic cells. J. Invest. Dermatol. 124, 1-12.
59. Valladeau, J., Saeland, S. (2005) Cutaneous dendritic cells. Semin. Immunol. 17, 273-283.
60. Wollenberg, A., Mommaas, M., Oppel, T., Schottdorf, E. M., Gunther, S., Moderer, M. (2002) Expression and function of the mannose receptor CD206 on epidermal dendritic cells in inflammatory skin diseases. J. Invest. Dermatol. 118, 327-334.
61. Headington, J. T. (1986) The dermal dendrocyte. Adv. Dermatol. 1, 159-171.
62. Cerio, R., Griffiths, C. E., Cooper, K. D., Nickoloff, B. J., Headington, J. T. (1989) Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin. Br. J. Dermatol. 121, 421-431.
63. Lenz, A., Heine, M., Schuler, G., Romani, N. (1993) Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization. J. Clin. Invest. 92, 2587-2596.
64. Turville, S. G., Cameron, P. U., Handley, A., Lin, G., Pohlmann, S., Doms, R. W., Cunningham, A. L. (2002) Diversity of receptors binding HIV on dendritic cell subsets. Nat. Immunol. 3, 975-983.
65. Breathnach, A. S., Birbeck, M. S., Everall, J. D. (1963) Observations bearing on the relationship between Langerhans cells and melanocytes. Ann. NY Acad. Sci. 192, 223-238.
66. Charbonnier, A. S., Kohrgruber, N., Kriehuber, E., Stingl, G., Rot, A., Maurer, D. (1999) Macrophage inflammatory protein 3α is involved in the constitutive trafficking of epidermal Langerhans cells. J. Exp. Med. 190, 1755-1768.
67. Tang, A., Amagai, M., Granger, L. G., Stanley, J. R., Udey, M. C. (1993) Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature 361, 82-85.
68. Valladeau, J., Ravel, O., Dezutter-Dambuyant, C., Moore, K., Kleijmeer, M., Liu, Y., Duvert-Frances, V., Vincent, C., Schmitt, D., Davoust, J., Caux, C., Lebecque, S., Saeland, S. (2000) Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12, 71-81.
69. Kim, K. D., Choi, S. C., Noh, Y. W., Kim, J. W., Paik, S. G., Yang, Y., Kim, K., Lim, J. S. (2006) Impaired responses of leukemic dendritic cells derived from a human myeloid cell line to LPS stimulation. Exp. Mol. Med. 38, 72-84.
70. Bontkes, H. J., Ruizendaal, J. J., Kramer, D., Santegoets, S. J., Scheper, R. J., de Gruijl, T. D., Meijer, C. J., Hooijberg, E. (2006) Constitutively active STAT5b induces cytokine-independent growth of the acute myeloid leukemia-derived MUTZ-3 cell line and accelerates its differentiation into mature dendritic cells. J. Immunother. 29, 188-200.
71. Haenssle, H., Buhl, T., Knudsen, S., Krueger, U., Rosenberger, A., Reich, K., Neumann, C. (2008) CD40 ligation during dendritic cell maturation reduces cell death and prevents interleukin-10-induced regression to macrophage-like monocytes. Exp. Dermatol. 17, 177-187.
72. Nestle, F. O., Banchereau, J., Hart, D. (2001) Dendritic cells: on the move from bench to bedside. Nat. Med. 7, 761-765.
73. Mailliard, R. B., Wankowicz-Kalinska, A., Cai, Q., Wesa, A., Hilkens, C. M., Kapsenberg, M. L., Kirkwood, J. M., Storkus, W. J., Kalinski, P. (2004) α-Type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity. Cancer Res. 64, 5934-5937.
74. Santegoets, S. J., Schreurs, M. W., Masterson, A. J., Liu, Y. P., Goletz, S., Baumeister, H., Kueter, E. W., Lougheed, S. M., van den Eertwegh, A. J., Scheper, R. J., Hooijberg, E., de Gruijl, T. D. (2006) In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line. Cancer Immunol. Immunother. 55, 1480-1490.
75. Curti, A., Pandolfi, S., Aluigi, M., Isidori, A., Alessandrini, I., Chiodoni, C., Testoni, N., Colombo, M. P., Baccarani, M., Lemoli, R. M. (2005) Interleukin-12 production by leukemia-derived dendritic cells counteracts the inhibitory effect of leukemic microenvironment on T cells. Exp. Hematol. 33, 1521-1530.
76. Luft, T., Jefford, M., Luetjens, P., Toy, T., Hochrein, H., Masterman, K. A., Maliszewski, C., Shortman, K., Cebon, J., Maraskovsky, E. (2002) Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets. Blood 100, 1362-1372.
77. Scandella, E., Men, Y., Legler, D. F., Gillessen, S., Prikler, L., Ludewig, B., Groettrup, M. (2004) CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2. Blood 103, 1595-1601.
78. Kalinski, P., Hilkens, C. M., Snijders, A., Snijdewint, F. G., Kapsenberg, M. L. (1997) IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J. Immunol. 159, 28-35.
79. Kalinski, P., Schuitemaker, J. H., Hilkens, C. M., Wierenga, E. A., Kapsenberg, M. L. (1999) Final maturation of dendritic cells is associated with impaired responsiveness to IFN-γ and to bacterial IL-12 inducers: decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells. J. Immunol. 162, 3231-3236.
80. Platzer, B., Jorgl, A., Taschner, S., Hocher, B., Strobl, H. (2004) RelB regulates human dendritic cell subset development by promoting monocyte intermediates. Blood 104, 3655-3663.
81. Jorgl, A., Platzer, B., Taschner, S., Heinz, L. X., Hocher, B., Reisner, P. M., Gobel, F., Strobl, H. (2007) Human Langerhans-cell activation triggered in vitro by conditionally expressed MKK6 is counterregulated by the downstream effector RelB. Blood 109, 185-193.
82. Jaksits, S., Kriehuber, E., Charbonnier, A. S., Rappersberger, K., Stingl, G., Maurer, D. (1999) CD34+ cell-derived CD14+ precursor cells develop into Langerhans cells in a TGF-β 1-dependent manner. J. Immunol. 163, 4869-4877.
83. Mohty, M., Isnardon, D., Blaise, D., Mozziconacci, M. J., Lafage-Pochitaloff, M., Briere, F., Gastaut, J. A., Olive, D., Gaugler, B. (2002) Identification of precursors of leukemic dendritic cells differentiated from patients with acute myeloid leukemia. Leukemia 16, 2267-2274.
84. Houtenbos, I., Westers, T. M., Ossenkoppele, G. J., van de Loosdrecht, A. A. (2003) Identification of CD14 as a predictor for leukemic dendritic cell differentiation in acute myeloid leukemia. Leukemia 17, 1683-1684.
85. Houtenbos, I., Westers, T. M., de Gruijl, T. D., Scheper, R. J., Ossenkoppele, G. J., van de Loosdrecht, A. A. (2004) TNF-α receptor 1 expression on acute myeloid leukemic blasts predicts differentiation into leukemic dendritic cells. Leukemia 18, 1149-1153.
86. Houtenbos, I., Westers, T. M., Hess, C. J., Waisfisz, Q., Ossenkoppele, G. J., van de Loosdrecht, A. A. (2006) Flt-3 internal tandem duplication hampers differentiation of AML blasts towards leukemic dendritic cells. Leukemia 20, 1892-1895.
87. Drexler, H. G. (2002) Monocytic cell lines. In: Human Cell Culture Vol. III, Part 3, Chptr. 7, pp. 237-257.
88. Goppelt-Struebe, M., Reiser, C. O., Schneider, N., Grell, M. (1996) Modulation of tumor necrosis factor (TNF) receptor expression during monocytic differentiation by glucocorticoids. Inflamm. Res. 45, 503-507.
89. Reiterer, G., Yen, A. (2007) Platelet-derived growth factor receptor regulates myeloid and monocytic differentiation of HL-60 cells. Cancer Res. 67, 7765-7772.
90. Sutheesophon, K., Nishimura, N., Kobayashi, Y., Furukawa, Y., Kawano, M., Itoh, K., Kano, Y., Ishii, H., Furukawa, Y. (2005) Involvement of the tumor necrosis factor (TNF)/TNF receptor system in leukemic cell apoptosis induced by histone deacetylase inhibitor depsipeptide (FK228). J. Cell. Physiol. 203, 387-397.
91. Cheng, T., Wang, Y., Dai, W. (1994) Transcription factor egr-1 is involved in phorbol 12-myristate 13-acetate-induced megakaryocytic differentiation of K562 cells. J. Biol. Chem. 269, 30848-30853.
92. Anderson, P., Sundstedt, A., Li, L., O'Neill, E. J., Li, S., Wraith, D. C., Wang, P. (2003) Differential activation of signal transducer and activator of transcription (STAT)3 and STAT5 and induction of suppressors of cytokine signaling in T(h)1 and T(h)2 cells. Int. Immunol. 15, 1309-1317.
93. Li, S., Ferguson, M. J., Hawkins, C. J., Smith, C., Elwood, N. J. (2006) Human telomerase reverse transcriptase protects hematopoietic progenitor TF-1 cells from death and quiescence induced by cytokine withdrawal. Leukemia 20, 1270-1278.
94. Nestle, F. O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G., Schadendorf, D. (1998) Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat. Med. 4, 328-332.
95. Thurner, B., Haendle, I., Röder, C., Dieckmann, D., Keikavoussi, P., Jonuleit, H., Bender, A., Maczek, C., Schreiner, D., von den Driesch, P., Bröcker, E. B., Steinman, R. M., Enk, A., Kämpgen, E., Schuler, G. (1999) Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J. Exp. Med. 190, 1669-1678.
96. Banchereau, J., Palucka, A. K., Dhodapkar, M., Burkeholder, S., Taquet, N., Rolland, A., Taquet, S., Coquery, S., Wittkowski, K. M., Bhardwaj, N., Pineiro, L., Steinman, R., Fay, J. (2001) Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitorderived dendritic cell vaccine. Cancer Res. 61, 6451-6458.
97. Davis, I. D., Jefford, M., Parente, P., Cebon, J. (2003) Rational approaches to human cancer immunotherapy. J. Leukoc. Biol. 73, 3-29.
98. Fabre, J. W. (2001) The allogeneic response and tumor immunity. Nat. Med. 7, 649-652.
99. Knight, S. C., Iqball, S., Roberts, M. S., Macatonia, S., Bedford, P. A. (1998) Transfer of antigen between dendritic cells in the stimulation of primary T cell proliferation. Eur. J. Immunol. 28, 1636-1644.
100. Harrop, R., John, J., Carroll, M. W. (2006) Recombinant viral vectors: cancer vaccines. Adv. Drug Deliv. Rev. 58, 931-947.
101. Doria-Rose, N. A., Haigwood, N. L. (2003) DNA vaccine strategies: candidates for immune modulation and immunization regimens. Methods 31, 207-216.
102. Brouwer, R. E., van der Hoorn, M., Kluin-Nelemans, H. C., van Zelderen-Bhola, S., Willemze, R., Falkenburg, J. H. (2000) The generation of dendritic-like cells with increased allostimulatory function from acute myeloid leukemia cells of various FAB subclasses. Hum. Immunol. 61, 565-574.
103. Rasaiyaah, J., Yong, K., Katz, D. R., Kellam, P., Chain, B. M. (2007) Dendritic cells and myeloid leukemias: plasticity and commitment in cell differentiation. Br. J. Haematol. 138, 281-290.